Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Charmaine Yam"'
Publikováno v:
BMJ Neurology Open, Vol 2, Iss 1 (2020)
Background Moyamoya is a rare cerebrovascular disorder seen predominantly in Asian populations. Methamphetamine use is a recognised cause of stroke in young people, but its pathophysiology is not fully understood. The incidence of moyamoya vasculopat
Externí odkaz:
https://doaj.org/article/b1178599cb164432a219c590cfedc624
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Concerns regarding infection with the novel coronavirus SARS-CoV-2 leading to COVID-19 are particularly marked for pregnant women with autoimmune diseases such as multiple sclerosis (MS). There is currently a relative paucity of information to guide
Autor:
Melissa Gresle, Jeanette Lechner-Scott, Trevor J. Kilpatrick, Helmut Butzkueven, Bruce V. Taylor, Michael Barnett, Charmaine Yam, Anneke van der Walt, Tomas Kalincik, David Darby, Jim Stankovich, Daniel Merlo
Publikováno v:
Multiple sclerosis and related disorders. 43
Monitoring and screening of cognitive function in the ambulatory setting requires simple, brief cognitive tests that are reproducible. MSReactor (MSR) is a web-based platform that screens psychomotor (processing) speed, attention and working memory u
Publikováno v:
Internal Medicine Journal. 49:274-276
Autor:
Stella Hughes, Ruth Dobson, David Rog, Katy Murray, Charmaine Yam, Peter Brex, Helen Ford, Owen R Pearson
Publikováno v:
Multiple Sclerosis and Related Disorders. 56:103272
Background The ABN Multiple Sclerosis (MS) pregnancy guidelines set out to combine best current evidence with expert consensus. They were developed to provide a practical framework to support neurologists when counselling women with MS regarding preg
Autor:
Charmaine Yam, Ruth Dobson
Publikováno v:
Advances in Clinical Neuroscience & Rehabilitation, Vol 19, Iss 3, Pp 15-16 (2020)
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 89:A15.1-A15
IntroductionThrombotic microangiopathy (TMA) has been described with long-term interferon-beta (IFN-β). We report a case of biopsy-proven TMA in a patient with multiple sclerosis (MS) who had been having IFN-β−1a injections for twenty years. Thes